Expression of suppressors of cytokine signaling in diseased periodontal tissues: a stop signal for disease progression?
暂无分享,去创建一个
G. Garlet | W. Martins | J. Silva | J S Silva | G P Garlet | C R Cardoso | A P Campanelli | W Martins | C. Cardoso | A. Campanelli | C. R. Cardoso
[1] G. Garlet,et al. Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. , 2003, Journal of periodontal research.
[2] G. Garlet,et al. Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. , 2004, Journal of clinical periodontology.
[3] A. Kantarcı,et al. Host-mediated resolution of inflammation in periodontal diseases. , 2006, Periodontology 2000.
[4] A. Yoshimura,et al. Negative regulation of cytokine and TLR signalings by SOCS and others. , 2005, Advances in immunology.
[5] M. Makuuchi,et al. Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression. , 2005, Journal of hepatology.
[6] W. B. van den Berg,et al. Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: exacerbation of joint inflammation in STAT-1 gene-knockout mice. , 2004, Arthritis and rheumatism.
[7] S. Akira,et al. Suppressor of cytokine signaling-1 selectively inhibits LPS-induced IL-6 production by regulating JAK-STAT. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[8] I. Cohen,et al. Heat Shock Protein 60 Activates Cytokine-Associated Negative Regulator Suppressor of Cytokine Signaling 3 in T Cells: Effects on Signaling, Chemotaxis, and Inflammation1 , 2005, The Journal of Immunology.
[9] L. Flowers,et al. Treatment of Mice with the Suppressor of Cytokine Signaling-1 Mimetic Peptide, Tyrosine Kinase Inhibitor Peptide, Prevents Development of the Acute Form of Experimental Allergic Encephalomyelitis and Induces Stable Remission in the Chronic Relapsing/Remitting Form1 , 2005, The Journal of Immunology.
[10] D. Curiel,et al. Suppressor of cytokine signaling-1 expression by infectivity-enhanced adenoviral vector inhibits IL-6-dependent proliferation of multiple myeloma cells , 2006, Cancer Gene Therapy.
[11] K. Heeg,et al. Suppressors of Cytokine Signaling (SOCS)-1 and SOCS-3 Are Induced by CpG-DNA and Modulate Cytokine Responses in APCs1 , 2001, The Journal of Immunology.
[12] Takafumi Yoshida,et al. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. , 2001, The Journal of clinical investigation.
[13] K. Heeg,et al. Suppressor of Cytokine Signaling (SOCS) Proteins Indirectly Regulate Toll-like Receptor Signaling in Innate Immune Cells*♦ , 2004, Journal of Biological Chemistry.
[14] N. Takahashi,et al. Regulatory mechanisms of osteoblast and osteoclast differentiation. , 2002, Oral diseases.
[15] D. Hebenstreit,et al. SOCS-1 and SOCS-3 inhibit IL-4 and IL-13 induced activation of Eotaxin-3/CCL26 gene expression in HEK293 cells. , 2005, Molecular immunology.
[16] Warren S. Alexander,et al. A family of cytokine-inducible inhibitors of signalling , 1997, Nature.
[17] A. Yoshimura,et al. Involvement of Suppressor of Cytokine Signaling-3 as a Mediator of the Inhibitory Effects of IL-10 on Lipopolysaccharide-Induced Macrophage Activation1 , 2002, The Journal of Immunology.
[18] Paul J Hertzog,et al. SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this Cytokine , 1999, Cell.
[19] Zhimin Feng,et al. Role of bacteria in health and disease of periodontal tissues. , 2006, Periodontology 2000.
[20] K. Rakesh,et al. Controlling cytokine signaling by constitutive inhibitors. , 2005, Biochemical pharmacology.
[21] J. Johndrow,et al. Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent , 2006, Nature Medicine.
[22] D. Kinane,et al. Generation of inflammatory stimuli: how bacteria set up inflammatory responses in the gingiva. , 2005, Journal of clinical periodontology.
[23] Kenji Nakanishi,et al. SOCS-1 participates in negative regulation of LPS responses. , 2002, Immunity.
[24] S. Nagata,et al. Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alpha-induced cell death in fibroblasts. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[25] W. Alexander,et al. Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation. , 2003, The Journal of clinical investigation.
[26] W. Alexander,et al. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. , 2004, Annual review of immunology.
[27] D. Häussinger,et al. The MKK6/p38 Mitogen-Activated Protein Kinase Pathway Is Capable of Inducing SOCS3 Gene Expression and Inhibits IL-6-Induced Transcription , 2001, Biological chemistry.
[28] A. Yoshimura,et al. Divergent Mechanisms Utilized by SOCS3 to Mediate Interleukin-10 Inhibition of Tumor Necrosis Factor α and Nitric Oxide Production by Macrophages* , 2006, Journal of Biological Chemistry.
[29] D. Kinane,et al. Advances in the pathogenesis of periodontitis. Group B consensus report of the fifth European Workshop in Periodontology. , 2005, Journal of clinical periodontology.
[30] Paul J Hertzog,et al. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation , 2006, Nature Immunology.
[31] R. Kent,et al. The interleukin-10 knockout mouse is highly susceptible to Porphyromonas gingivalis-induced alveolar bone loss. , 2004, Journal of periodontal research.
[32] K. Eguchi,et al. Increased mRNA expression of Th1-cytokine signaling molecules in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. , 2004, The Tohoku journal of experimental medicine.
[33] T. Berglundh,et al. Aspects of adaptive host response in periodontitis. , 2005, Journal of clinical periodontology.
[34] A. Kantarcı,et al. Lipoxin signaling in neutrophils and their role in periodontal disease. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.
[35] D. Graves,et al. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. , 2003, Journal of periodontology.
[36] D. Kinane,et al. Immune processes in periodontal disease: a review. , 2002, Annals of periodontology.